Company Profile

Acurx Pharmaceuticals is a publicly held clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections. Acurx's approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme and its R&D pipeline includes early stage antibiotic candidates that target other Gram-positive bacteria, including Methicillin-Resistant Staphylococcus aureus (MRSA), Vancomycin- Resistant Enterococcus (VRE) and Penicillin-Resistant Streptococcus pneumoniae (PRSP).

Latest Presentation

Industry Classifications

Sector:
Pharmaceuticals

Industry:
Healthcare

NAICS:
Pharmaceutical and Medicine Manufacturing (32541)

SIC:
Pharmaceutical Preparations (2834)

Contact Information

Investor Relations
In-Site Communications
Lisa Wilson

Company Contact
Acurx Pharmaceuticals, LLC
259 Liberty Avenue
Staten Island, NY 10305